Anne Marie Falk

Array ( [id] => 3933672 [patent_doc_number] => 05929041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product' [patent_app_type] => 1 [patent_app_number] => 8/710219 [patent_app_country] => US [patent_app_date] => 1996-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19545 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929041.pdf [firstpage_image] =>[orig_patent_app_number] => 710219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208906 [patent_doc_number] => 06713247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Human CNS cell lines and methods of use therefor' [patent_app_type] => B1 [patent_app_number] => 08/711628 [patent_app_country] => US [patent_app_date] => 1996-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 47 [patent_no_of_words] => 14247 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713247.pdf [firstpage_image] =>[orig_patent_app_number] => 08711628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826765 [patent_doc_number] => 07402429 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-22 [patent_title] => 'Host cells comprising cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, further encoding antigenically active proteins' [patent_app_type] => utility [patent_app_number] => 09/011425 [patent_app_country] => US [patent_app_date] => 1996-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 14692 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402429.pdf [firstpage_image] =>[orig_patent_app_number] => 09011425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1569601 [patent_doc_number] => 06497872 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Neural transplantation using proliferated multipotent neural stem cells and their progeny' [patent_app_type] => B1 [patent_app_number] => 08/486313 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 35961 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/497/06497872.pdf [firstpage_image] =>[orig_patent_app_number] => 08486313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930407 [patent_doc_number] => 05980885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Growth factor-induced proliferation of neural precursor cells in vivo' [patent_app_type] => 1 [patent_app_number] => 8/486307 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36223 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980885.pdf [firstpage_image] =>[orig_patent_app_number] => 486307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4118343 [patent_doc_number] => 06071889 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'In vivo genetic modification of growth factor-responsive neural precursor cells' [patent_app_type] => 1 [patent_app_number] => 8/479795 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 36206 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071889.pdf [firstpage_image] =>[orig_patent_app_number] => 479795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 539155 [patent_doc_number] => 07166277 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-23 [patent_title] => 'Remyelination of neurons using multipotent neural stem cell progeny' [patent_app_type] => utility [patent_app_number] => 08/479796 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 35939 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166277.pdf [firstpage_image] =>[orig_patent_app_number] => 08479796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1270695 [patent_doc_number] => 06653291 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Composition and method for production of transformed cells' [patent_app_type] => B1 [patent_app_number] => 08/390700 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3989 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653291.pdf [firstpage_image] =>[orig_patent_app_number] => 08390700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1451670 [patent_doc_number] => 06455756 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice' [patent_app_type] => B1 [patent_app_number] => 08/290038 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8840 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455756.pdf [firstpage_image] =>[orig_patent_app_number] => 08290038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4068089 [patent_doc_number] => 05965149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Granular formulation of biological entities with improved storage stability' [patent_app_type] => 1 [patent_app_number] => 8/284072 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 9119 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965149.pdf [firstpage_image] =>[orig_patent_app_number] => 284072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1559504 [patent_doc_number] => 06436701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Derivation of pluripotential embryonic cell lines from ungulate species' [patent_app_type] => B1 [patent_app_number] => 07/669403 [patent_app_country] => US [patent_app_date] => 1991-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 6987 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436701.pdf [firstpage_image] =>[orig_patent_app_number] => 07669403 [rel_patent_id] =>[rel_patent_doc_number] =>)